Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline ...
Low total cholesterol levels were tied to an increased risk of death for pulmonary fibrosis patients with disease of unknown ...
Nerandomilast worked better than a placebo to preserve lung function in adults with progressive pulmonary fibrosis in a Phase ...
Topline data from FIBRONEERâ„¢-ILD show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change ...
Nerandomilast, an oral phosphodiesterase 4B inhibitor, hit the primary endpoint in a Phase III trial in progressive pulmonary ...
Did you see this? Nearly 1 in 10 Americans have asthma. Here's what causes it.
Boehringer Ingelheim has cemented the potential of its idiopathic pulmonary fibrosis (IPF) drug with a second phase 3 win in ...
Researchers have been trying for decades to stop the cells that damage the lung in people with pulmonary fibrosis. Now a team ...
Dyspnea, the sensation of breathlessness or labored breathing, commonly occurs in patients with chronic pulmonary disease. Cystic fibrosis (CF) is an autosomal recessive disorder that affects the ...
Chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis (also called idiopathic pulmonary fibrosis, or IPF) are both serious lifelong diseases that make it hard for you to breathe.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback